Twist Bioscience Corporation (TWST) Tops Q1 EPS by 2c, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus

Go back to Twist Bioscience Corporation (TWST) Tops Q1 EPS by 2c, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus
(NASDAQ: TWST) Delayed: 120.52 -4.77 (3.81%)
Previous Close $125.29    52 Week High
Open $124.09    52 Week Low
Day High $124.71    P/E N/A 
Day Low $120.50    EPS
Volume 69,388